APO Research

APO RESEARCH · REPORT

Biomedical Cold Chain Services

Selected research

Market Outlook & Growth Opportunities

Global Biomedical Cold Chain Services Market Outlook and Growth Opportunities 2026

Market perspective

The global Biomedical Cold Chain Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biomedical Cold Chain Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biomedical Cold Chain Services market include Csafe, DS Smith, Skycell, Sofrigam, Cold Chain Technologies, Nichirei Logistics Group, Sonoco, Alloga and Hemisphere Freight Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biomedical Cold Chain Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomedical Cold Chain Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomedical Cold Chain Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomedical Cold Chain Services market.

Biomedical Cold Chain Services Segment by Company

Csafe

DS Smith

Skycell

Sofrigam

Cold Chain Technologies

Nichirei Logistics Group

Sonoco

Alloga

Hemisphere Freight Services

TEK Freight

Jump Up Logistics

Courier Express

Biocair

Tower Cold Chain

Patheon

Movianto

Pharmaceutical Technology

Biomedical Cold Chain Services Segment by Type

Shipping

Air Transport

Land Transportation

Others

Biomedical Cold Chain Services Segment by Application

Pharmaceuticals

Blood Supplies

Others

Biomedical Cold Chain Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomedical Cold Chain Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomedical Cold Chain Services key companies, revenue, market share, and recent developments.

3. To split the Biomedical Cold Chain Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomedical Cold Chain Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomedical Cold Chain Services significant trends, drivers, influence factors in global and regions.

6. To analyze Biomedical Cold Chain Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Cold Chain Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical Cold Chain Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Cold Chain Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical Cold Chain Services industry.

Chapter 3: Detailed analysis of Biomedical Cold Chain Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomedical Cold Chain Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomedical Cold Chain Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomedical Cold Chain Services Industry Trends Table 2. Biomedical Cold Chain Services Industry Drivers Table 3. Biomedical Cold Chain Services Industry Opportunities and Challenges Table 4. Biomedical Cold Chain Services Industry Restraints Table 5. Global Biomedical Cold Chain Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomedical Cold Chain Services Revenue Share by Company (2021-2026) Table 7. Global Biomedical Cold Chain Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomedical Cold Chain Services Key Company Manufacturing Base & Headquarters Table 9. Global Biomedical Cold Chain Services Company, Product Type & Application Table 10. Global Biomedical Cold Chain Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomedical Cold Chain Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Shipping Table 15. Significant Companies of Air Transport Table 16. Significant Companies of Land Transportation Table 17. Significant Companies of Others Table 18. Global Biomedical Cold Chain Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Biomedical Cold Chain Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Biomedical Cold Chain Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Biomedical Cold Chain Services Sales Value Share by Type (2021-2026) Table 22. Global Biomedical Cold Chain Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceuticals Table 24. Significant Companies of Blood Supplies Table 25. Significant Companies of Others Table 26. Global Biomedical Cold Chain Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biomedical Cold Chain Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Biomedical Cold Chain Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Biomedical Cold Chain Services Sales Value Share by Application (2021-2026) Table 30. Global Biomedical Cold Chain Services Sales Value Share by Application (2027-2032) Table 31. Global Biomedical Cold Chain Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biomedical Cold Chain Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Biomedical Cold Chain Services Sales Value Share by Region (2021-2026) Table 34. Global Biomedical Cold Chain Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Biomedical Cold Chain Services Sales Value Share by Region (2027-2032) Table 36. Global Biomedical Cold Chain Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Biomedical Cold Chain Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Biomedical Cold Chain Services Sales Value Market Share by Country (2021-2026) Table 39. Global Biomedical Cold Chain Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Biomedical Cold Chain Services Sales Value Market Share by Country (2027-2032) Table 41. Csafe Company Information Table 42. Csafe Business Overview Table 43. Csafe Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Csafe Biomedical Cold Chain Services Product Portfolio Table 45. Csafe Recent Development Table 46. DS Smith Company Information Table 47. DS Smith Business Overview Table 48. DS Smith Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. DS Smith Biomedical Cold Chain Services Product Portfolio Table 50. DS Smith Recent Development Table 51. Skycell Company Information Table 52. Skycell Business Overview Table 53. Skycell Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Skycell Biomedical Cold Chain Services Product Portfolio Table 55. Skycell Recent Development Table 56. Sofrigam Company Information Table 57. Sofrigam Business Overview Table 58. Sofrigam Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sofrigam Biomedical Cold Chain Services Product Portfolio Table 60. Sofrigam Recent Development Table 61. Cold Chain Technologies Company Information Table 62. Cold Chain Technologies Business Overview Table 63. Cold Chain Technologies Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio Table 65. Cold Chain Technologies Recent Development Table 66. Nichirei Logistics Group Company Information Table 67. Nichirei Logistics Group Business Overview Table 68. Nichirei Logistics Group Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio Table 70. Nichirei Logistics Group Recent Development Table 71. Sonoco Company Information Table 72. Sonoco Business Overview Table 73. Sonoco Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sonoco Biomedical Cold Chain Services Product Portfolio Table 75. Sonoco Recent Development Table 76. Alloga Company Information Table 77. Alloga Business Overview Table 78. Alloga Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Alloga Biomedical Cold Chain Services Product Portfolio Table 80. Alloga Recent Development Table 81. Hemisphere Freight Services Company Information Table 82. Hemisphere Freight Services Business Overview Table 83. Hemisphere Freight Services Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio Table 85. Hemisphere Freight Services Recent Development Table 86. TEK Freight Company Information Table 87. TEK Freight Business Overview Table 88. TEK Freight Biomedical Cold Chain Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. TEK Freight Biomedical Cold Chain Services Product Portfolio Table 90. TEK Freight Recent Development Table 91. Jump Up Logistics Company Information Table 92. Jump Up Logistics Business Overview Table 93. Jump Up Logistics Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Jump Up Logistics Biomedical Cold Chain Services Product Portfolio Table 95. Jump Up Logistics Recent Development Table 96. Courier Express Company Information Table 97. Courier Express Business Overview Table 98. Courier Express Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Courier Express Biomedical Cold Chain Services Product Portfolio Table 100. Courier Express Recent Development Table 101. Biocair Company Information Table 102. Biocair Business Overview Table 103. Biocair Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Biocair Biomedical Cold Chain Services Product Portfolio Table 105. Biocair Recent Development Table 106. Tower Cold Chain Company Information Table 107. Tower Cold Chain Business Overview Table 108. Tower Cold Chain Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Tower Cold Chain Biomedical Cold Chain Services Product Portfolio Table 110. Tower Cold Chain Recent Development Table 111. Patheon Company Information Table 112. Patheon Business Overview Table 113. Patheon Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Patheon Biomedical Cold Chain Services Product Portfolio Table 115. Patheon Recent Development Table 116. Movianto Company Information Table 117. Movianto Business Overview Table 118. Movianto Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Movianto Biomedical Cold Chain Services Product Portfolio Table 120. Movianto Recent Development Table 121. Pharmaceutical Technology Company Information Table 122. Pharmaceutical Technology Business Overview Table 123. Pharmaceutical Technology Biomedical Cold Chain Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio Table 125. Pharmaceutical Technology Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Biomedical Cold Chain Services Product Image Figure 2. Global Biomedical Cold Chain Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical Cold Chain Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomedical Cold Chain Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Shipping Image Figure 8. Air Transport Image Figure 9. Land Transportation Image Figure 10. Others Image Figure 11. Global Biomedical Cold Chain Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Biomedical Cold Chain Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Biomedical Cold Chain Services Sales Value Share by Type (2021-2032) Figure 14. Pharmaceuticals Image Figure 15. Blood Supplies Image Figure 16. Others Image Figure 17. Global Biomedical Cold Chain Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biomedical Cold Chain Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Biomedical Cold Chain Services Sales Value Share by Application (2021-2032) Figure 20. Global Biomedical Cold Chain Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Biomedical Cold Chain Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Biomedical Cold Chain Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Biomedical Cold Chain Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Biomedical Cold Chain Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Biomedical Cold Chain Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Biomedical Cold Chain Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Biomedical Cold Chain Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Biomedical Cold Chain Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Biomedical Cold Chain Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Biomedical Cold Chain Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Biomedical Cold Chain Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Shipping
  • Air Transport
  • Land Transportation
  • Others
Applications
  • Pharmaceuticals
  • Blood Supplies
  • Others
Companies covered
  • Csafe
  • DS Smith
  • Skycell
  • Sofrigam
  • Cold Chain Technologies
  • Nichirei Logistics Group
  • Sonoco
  • Alloga
  • Hemisphere Freight Services
  • TEK Freight
  • Jump Up Logistics
  • Courier Express
  • Biocair
  • Tower Cold Chain
  • Patheon
  • Movianto
  • Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomedical Cold Chain Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomedical Cold Chain Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomedical Cold Chain Services Market Dynamics
  1. 2.1 Biomedical Cold Chain Services Industry Trends
  2. 2.2 Biomedical Cold Chain Services Industry Drivers
  3. 2.3 Biomedical Cold Chain Services Industry Opportunities and Challenges
  4. 2.4 Biomedical Cold Chain Services Industry Restraints
3 Biomedical Cold Chain Services Market by Company
  1. 3.1 Global Biomedical Cold Chain Services Company Revenue Ranking in 2025
  2. 3.2 Global Biomedical Cold Chain Services Revenue by Company (2021-2026)
  3. 3.3 Global Biomedical Cold Chain Services Company Ranking (2024-2026)
  4. 3.4 Global Biomedical Cold Chain Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomedical Cold Chain Services Company Product Type and Application
  6. 3.6 Global Biomedical Cold Chain Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomedical Cold Chain Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomedical Cold Chain Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomedical Cold Chain Services Market by Type
  1. 4.1 Biomedical Cold Chain Services Type Introduction
  2. 4.1.1 Shipping
  3. 4.1.2 Air Transport
  4. 4.1.3 Land Transportation
  5. 4.1.4 Others
  6. 4.2 Global Biomedical Cold Chain Services Sales Value by Type
  7. 4.2.1 Global Biomedical Cold Chain Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biomedical Cold Chain Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Biomedical Cold Chain Services Sales Value Share by Type (2021-2032)
5 Biomedical Cold Chain Services Market by Application
  1. 5.1 Biomedical Cold Chain Services Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Blood Supplies
  4. 5.1.3 Others
  5. 5.2 Global Biomedical Cold Chain Services Sales Value by Application
  6. 5.2.1 Global Biomedical Cold Chain Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biomedical Cold Chain Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biomedical Cold Chain Services Sales Value Share by Application (2021-2032)
6 Biomedical Cold Chain Services Regional Value Analysis
  1. 6.1 Global Biomedical Cold Chain Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomedical Cold Chain Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomedical Cold Chain Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomedical Cold Chain Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomedical Cold Chain Services Sales Value (2021-2032)
  7. 6.3.2 North America Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomedical Cold Chain Services Sales Value (2021-2032)
  10. 6.4.2 Europe Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomedical Cold Chain Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomedical Cold Chain Services Sales Value (2021-2032)
  16. 6.6.2 South America Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomedical Cold Chain Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
7 Biomedical Cold Chain Services Country-level Value Analysis
  1. 7.1 Global Biomedical Cold Chain Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomedical Cold Chain Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomedical Cold Chain Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomedical Cold Chain Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Csafe
  2. 8.1.1 Csafe Company Information
  3. 8.1.2 Csafe Business Overview
  4. 8.1.3 Csafe Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Csafe Biomedical Cold Chain Services Product Portfolio
  6. 8.1.5 Csafe Recent Developments
  7. 8.2 DS Smith
  8. 8.2.1 DS Smith Company Information
  9. 8.2.2 DS Smith Business Overview
  10. 8.2.3 DS Smith Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DS Smith Biomedical Cold Chain Services Product Portfolio
  12. 8.2.5 DS Smith Recent Developments
  13. 8.3 Skycell
  14. 8.3.1 Skycell Company Information
  15. 8.3.2 Skycell Business Overview
  16. 8.3.3 Skycell Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Skycell Biomedical Cold Chain Services Product Portfolio
  18. 8.3.5 Skycell Recent Developments
  19. 8.4 Sofrigam
  20. 8.4.1 Sofrigam Company Information
  21. 8.4.2 Sofrigam Business Overview
  22. 8.4.3 Sofrigam Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sofrigam Biomedical Cold Chain Services Product Portfolio
  24. 8.4.5 Sofrigam Recent Developments
  25. 8.5 Cold Chain Technologies
  26. 8.5.1 Cold Chain Technologies Company Information
  27. 8.5.2 Cold Chain Technologies Business Overview
  28. 8.5.3 Cold Chain Technologies Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio
  30. 8.5.5 Cold Chain Technologies Recent Developments
  31. 8.6 Nichirei Logistics Group
  32. 8.6.1 Nichirei Logistics Group Company Information
  33. 8.6.2 Nichirei Logistics Group Business Overview
  34. 8.6.3 Nichirei Logistics Group Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio
  36. 8.6.5 Nichirei Logistics Group Recent Developments
  37. 8.7 Sonoco
  38. 8.7.1 Sonoco Company Information
  39. 8.7.2 Sonoco Business Overview
  40. 8.7.3 Sonoco Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sonoco Biomedical Cold Chain Services Product Portfolio
  42. 8.7.5 Sonoco Recent Developments
  43. 8.8 Alloga
  44. 8.8.1 Alloga Company Information
  45. 8.8.2 Alloga Business Overview
  46. 8.8.3 Alloga Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Alloga Biomedical Cold Chain Services Product Portfolio
  48. 8.8.5 Alloga Recent Developments
  49. 8.9 Hemisphere Freight Services
  50. 8.9.1 Hemisphere Freight Services Company Information
  51. 8.9.2 Hemisphere Freight Services Business Overview
  52. 8.9.3 Hemisphere Freight Services Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio
  54. 8.9.5 Hemisphere Freight Services Recent Developments
  55. 8.10 TEK Freight
  56. 8.10.1 TEK Freight Company Information
  57. 8.10.2 TEK Freight Business Overview
  58. 8.10.3 TEK Freight Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TEK Freight Biomedical Cold Chain Services Product Portfolio
  60. 8.10.5 TEK Freight Recent Developments
  61. 8.11 Jump Up Logistics
  62. 8.11.1 Jump Up Logistics Company Information
  63. 8.11.2 Jump Up Logistics Business Overview
  64. 8.11.3 Jump Up Logistics Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jump Up Logistics Biomedical Cold Chain Services Product Portfolio
  66. 8.11.5 Jump Up Logistics Recent Developments
  67. 8.12 Courier Express
  68. 8.12.1 Courier Express Company Information
  69. 8.12.2 Courier Express Business Overview
  70. 8.12.3 Courier Express Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Courier Express Biomedical Cold Chain Services Product Portfolio
  72. 8.12.5 Courier Express Recent Developments
  73. 8.13 Biocair
  74. 8.13.1 Biocair Company Information
  75. 8.13.2 Biocair Business Overview
  76. 8.13.3 Biocair Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biocair Biomedical Cold Chain Services Product Portfolio
  78. 8.13.5 Biocair Recent Developments
  79. 8.14 Tower Cold Chain
  80. 8.14.1 Tower Cold Chain Company Information
  81. 8.14.2 Tower Cold Chain Business Overview
  82. 8.14.3 Tower Cold Chain Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tower Cold Chain Biomedical Cold Chain Services Product Portfolio
  84. 8.14.5 Tower Cold Chain Recent Developments
  85. 8.15 Patheon
  86. 8.15.1 Patheon Company Information
  87. 8.15.2 Patheon Business Overview
  88. 8.15.3 Patheon Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Patheon Biomedical Cold Chain Services Product Portfolio
  90. 8.15.5 Patheon Recent Developments
  91. 8.16 Movianto
  92. 8.16.1 Movianto Company Information
  93. 8.16.2 Movianto Business Overview
  94. 8.16.3 Movianto Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Movianto Biomedical Cold Chain Services Product Portfolio
  96. 8.16.5 Movianto Recent Developments
  97. 8.17 Pharmaceutical Technology
  98. 8.17.1 Pharmaceutical Technology Company Information
  99. 8.17.2 Pharmaceutical Technology Business Overview
  100. 8.17.3 Pharmaceutical Technology Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio
  102. 8.17.5 Pharmaceutical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research